HANG SAITO: Open Payments
NPI 1629153309 · EWA BEACH, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,817 in 78 payments from 12 companies in 2025. Trend: 2023 $1,758 · 2024 $2,060 · 2025 $1,817
Food & beverage: $1,817
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 21 | $391 |
| Lilly USA, LLC | 14 | $278 |
| Insulet Corporation | 5 | $226 |
| Dexcom, Inc. | 6 | $192 |
| Xeris Pharmaceuticals, Inc. | 8 | $150 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $150 |
| Abbott Laboratories | 8 | $148 |
| Mannkind Corporation | 4 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $87 |
| Corcept Therapeutics | 1 | $35 |
Products named: Omnipod, MOUNJARO, Dexcom G6 Transmitter, JARDIANCE, FREESTYLE LIBRE 3, RECORLEV, AFREZZA, Kerendia.
Industry payments across HI — which companies pay providers there.
